What is Evolved By Nature?
Founded in 2013 by Drs. Gregory Altman and Rebecca Lacouture, Evolved By Nature operates at the intersection of biotechnology and industrial chemistry. The company's core innovation, Liquid Silk, serves as a sustainable, biodegradable, and biocompatible substitute for synthetic finishing chemicals. By replacing harmful petrochemicals with natural, silk-derived proteins, the firm enables brands to meet stringent environmental, social, and governance (ESG) standards without compromising on product efficacy. Its dual-track business model—spanning direct-to-consumer clinical skincare and B2B partnerships with global fashion houses—demonstrates a versatile application of its patented chemistry platform, effectively disrupting legacy supply chains with greener, more resilient material solutions.
How much funding has Evolved By Nature raised?
Evolved By Nature has raised a total of $161M across 3 funding rounds:
Series A
$11M
Series B
$30M
Series C
$120M
Series A (2017): $11M with participation from Skyview Capital
Series B (2018): $30M, investors not publicly disclosed
Series C (2022): $120M supported by Ontario Teachers Pension Plan, Mousse Partners, and Senator Investment Group
Key Investors in Evolved By Nature
Ontario Teachers Pension Plan
A major Canadian institutional investor managing pension assets with a focus on long-term growth and sustainable infrastructure investments.
Mousse Partners
A private investment firm that emphasizes brand integrity and strategic capital allocation across diverse global markets.
Senator Investment Group
A New York-based investment firm specializing in asset allocation across public equity and fixed income markets globally.
What's next for Evolved By Nature?
With the successful closure of this major enterprise-level funding round, Evolved By Nature is poised to accelerate its manufacturing capabilities and expand its footprint in the global textile and consumer goods markets. The strategic focus will likely shift toward scaling the production of its Liquid Silk platform to meet the demands of large-scale industrial partners. As the company matures, the emphasis will remain on deepening its intellectual property moat and refining its supply chain logistics to ensure that its sustainable chemistry remains a cost-competitive alternative to conventional synthetic agents. Investors are closely watching the firm's ability to integrate its technology into broader, high-volume manufacturing ecosystems, which will be the primary driver of its long-term valuation and market dominance.
See full Evolved By Nature company page
